Global cancer statistics, 2012

Cancer constitutes an enormous burden on society in more and less economically developed countries alike. The occurrence of cancer is increasing because of the growth and aging of the population, as well as an increasing prevalence of established risk factors such as smoking, overweight, physical inactivity, and changing reproductive patterns associated with urbanization and economic development. Based on GLOBOCAN estimates, about 14.1 million new cancer cases and 8.2 million deaths occurred in 2012 worldwide. Over the years, the burden has shifted to less developed countries, which currently account for about 57% of cases and 65% of cancer deaths worldwide. Lung cancer is the leading cause of cancer death among males in both more and less developed countries, and has surpassed breast cancer as the leading cause of cancer death among females in more developed countries; breast cancer remains the leading cause of cancer death among females in less developed countries. Other leading causes of cancer death in more developed countries include colorectal cancer among males and females and prostate cancer among males. In less developed countries, liver and stomach cancer among males and cervical cancer among females are also leading causes of cancer death. Although incidence rates for all cancers combined are nearly twice as high in more developed than in less developed countries in both males and females, mortality rates are only 8% to 15% higher in more developed countries. This disparity reflects regional differences in the mix of cancers, which is affected by risk factors and detection practices, and/or the availability of treatment. Risk factors associated with the leading causes of cancer death include tobacco use (lung, colorectal, stomach, and liver cancer), overweight/obesity and physical inactivity (breast and colorectal cancer), and infection (liver, stomach, and cervical cancer). A substantial portion of cancer cases and deaths could be prevented by broadly applying effective prevention measures, such as tobacco control, vaccination, and the use of early detection tests. CA Cancer J Clin 2015;65: 87–108. © 2015 American Cancer Society.

[1]  J A TAIANA,et al.  [Cancer of the lung]. , 1952, The Journal of the International College of Surgeons.

[2]  F. Lahey [Cancers of the colon and rectum]. , 1952, Archivos medicos de Cuba.

[3]  I. Todd Cancer of the Lung , 1975, British Journal of Cancer.

[4]  K. Carsky [Prevention of gastric cancer]. , 1954, Lekarsky obzor.

[5]  L. Breslow,et al.  Air pollution and cancer. , 1960, Proceedings. National Cancer Conference.

[6]  栗原 登,et al.  Trends cancer mortality for selected sites in 24 countries , 1960 .

[7]  A. G. Oettlé Geographical and racial differences in the frequency of Kaposi's sarcoma as evidence of environmental or genetic causes. , 1962, Acta - Unio Internationalis Contra Cancrum.

[8]  Oettlé Ag Geographical and racial differences in the frequency of Kaposi's sarcoma as evidence of environmental or genetic causes. , 1962 .

[9]  P. Cook,et al.  Summarizing indices for comparison of cancer incidence data , 1967, International journal of cancer.

[10]  L. Böttiger [The cause of infectious mononucleosis?]. , 1969, Nordisk medicin.

[11]  B. Le Cause of infectious mononucleosis. , 1969, Nursing mirror and midwives journal.

[12]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[13]  S. Horiguchi,et al.  [Nasopharyngeal cancer]. , 1973, Nihon Jibiinkoka Gakkai kaiho.

[14]  P. Buell The effect of migration on the risk of nasopharyngeal cancer among Chinese. , 1974, Cancer research.

[15]  M. Plummer,et al.  International agency for research on cancer. , 2020, Archives of pathology.

[16]  W. Montorsi [Cancer of the lung]. , 1975, Minerva medica.

[17]  M. Hutt The epidemiology of Kaposi's sarcoma. , 1981, Antibiotics and chemotherapy.

[18]  P. Levine,et al.  Early primary infection and high Epstein‐barr virus antibody titers in greenland eskimos at high risk for nasopharyngeal carcinoma , 1984, International journal of cancer.

[19]  D. Woodfield Hepatocellular carcinoma. , 1986, The New Zealand medical journal.

[20]  E. Wynder,et al.  The decline in gastric cancer: epidemiology of an unplanned triumph. , 1986, Epidemiologic reviews.

[21]  D. Winn,et al.  Smoking and drinking in relation to oral and pharyngeal cancer. , 1988, Cancer research.

[22]  G. Pershagen,et al.  Air pollution and cancer. , 1990, IARC scientific publications.

[23]  V. Beral,et al.  AIDS-associated non-Hodgkin lymphoma , 1991, The Lancet.

[24]  John W. Ward,et al.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. , 1993, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[25]  T. Fears,et al.  Non-Hodgkin's lymphoma time trends: United States and international data. , 1992, Cancer research.

[26]  P. Hartge,et al.  Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence. , 1992, Cancer research.

[27]  V. Beral,et al.  The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. , 1998, British Journal of Cancer.

[28]  V. Beral,et al.  Antibodies against human herpesvirus 8 in black South African patients with cancer. , 1999, The New England journal of medicine.

[29]  V. Beral,et al.  International collaboration on HIV and cancer , 2000 .

[30]  V. Beral,et al.  Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. , 2000 .

[31]  Marina Manca,et al.  The decline of , 2000 .

[32]  A. Jemal,et al.  Breast Cancer Statistics , 2013 .

[33]  V. Beral,et al.  Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. , 2000, Journal of the National Cancer Institute.

[34]  T. Schulz KSHV (HHV8) infection. , 2000, The Journal of infection.

[35]  R. Coutinho,et al.  Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults , 2000 .

[36]  Leslie T. Stayner,et al.  IARC Monographs on the evaluation of carcinogenic risks to humans: Some traditional herbal medicines, some mycotoxins, naphthalene and styrene , 2002 .

[37]  G. Klein Nasopharyngeal carcinoma (NPC) is an enigmatic tumor. , 2002, Seminars in cancer biology.

[38]  Iarc Monographs Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. , 2002, IARC monographs on the evaluation of carcinogenic risks to humans.

[39]  A. Jemal,et al.  Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. , 2002, Journal of the National Cancer Institute.

[40]  W. Sze,et al.  Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20‐year period (1980–99): An encouraging reduction in both incidence and mortality , 2003, International journal of cancer.

[41]  R. Malekzadeh,et al.  Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran , 2004, British Journal of Cancer.

[42]  M. Chan-yeung,et al.  Lung cancer epidemiology and risk factors in Asia and Africa. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[43]  D. Berry,et al.  Effect of screening and adjuvant therapy on mortality from breast cancer. , 2006, The New England journal of medicine.

[44]  Alan D. Lopez,et al.  Counting the dead and what they died from: an assessment of the global status of cause of death data. , 2005, Bulletin of the World Health Organization.

[45]  L. Brinton,et al.  Global trends in breast cancer incidence and mortality 1973-1997. , 2005, International journal of epidemiology.

[46]  C. Abnet,et al.  Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China , 2005, International journal of cancer.

[47]  N. Weiss,et al.  Trends in the incidence rates of nasopharyngeal carcinoma among Chinese Americans living in Los Angeles County and the San Francisco metropolitan area, 1992-2002. , 2005, American journal of epidemiology.

[48]  Majid Ezzati,et al.  Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors , 2005, The Lancet.

[49]  H. Adami,et al.  Trends in incidence and mortality of nasopharyngeal carcinoma over a 20–25 year period (1978/1983–2002) in Sihui and Cangwu counties in southern China , 2006, BMC Cancer.

[50]  D. Parkin,et al.  The evolution of the population-based cancer registry , 2006, Nature Reviews Cancer.

[51]  T. Sellers,et al.  Epidemiology — identifying the causes and preventability of cancer? , 2006, Nature Reviews Cancer.

[52]  D. Parkin,et al.  The global health burden of infection‐associated cancers in the year 2002 , 2006, International journal of cancer.

[53]  Chiun Hsu,et al.  Difference in the Incidence Trend of Nasopharyngeal and Oropharyngeal Carcinomas in Taiwan: Implication from Age-Period-Cohort Analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.

[54]  H. Adami,et al.  The Enigmatic Epidemiology of Nasopharyngeal Carcinoma , 2006, Cancer Epidemiology Biomarkers & Prevention.

[55]  H. Iwase,et al.  [Breast cancer]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[56]  M. Thun,et al.  American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention: Reducing the Risk of Cancer With Healthy Food Choices and Physical Activity , 2002, CA: a cancer journal for clinicians.

[57]  J. Fraumeni,et al.  Cancer epidemiology and prevention. , 2006 .

[58]  F. Bray,et al.  Predicting the future burden of cancer , 2006, Nature Reviews Cancer.

[59]  S. Winawer The multidisciplinary management of gastrointestinal cancer. Colorectal cancer screening. , 2007, Best practice & research. Clinical gastroenterology.

[60]  F. Clavel-Chapelon,et al.  Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC) , 2007, International journal of cancer.

[61]  Eric J Feuer,et al.  The decrease in breast-cancer incidence in 2003 in the United States. , 2007, The New England journal of medicine.

[62]  B. Flehinger,et al.  Colorectal cancer screening. , 1991, Journal of the National Cancer Institute.

[63]  K. Chia,et al.  Secular trends of nasopharyngeal carcinoma incidence in Singapore, Hong Kong and Los Angeles Chinese populations, 1973–1997 , 2007, European Journal of Epidemiology.

[64]  Susanna M Cramb,et al.  The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[65]  P. Maisonneuve,et al.  Smoking and colorectal cancer: a meta-analysis. , 2008, JAMA.

[66]  B. Edwards,et al.  Sustained lower rates of breast cancer in the United States , 2009, Breast Cancer Research and Treatment.

[67]  Xiao-Cheng Wu,et al.  Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control , 2008, Journal of the National Cancer Institute.

[68]  D. Parkin,et al.  The global burden of urinary bladder cancer , 2008, Scandinavian journal of urology and nephrology. Supplementum.

[69]  F. Islami,et al.  Helicobacter pylori and Esophageal Cancer Risk: A Meta-analysis , 2008, Cancer Prevention Research.

[70]  D. Parkin Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy? , 2009, European journal of cancer.

[71]  A. Jemal,et al.  Worldwide Variations in Colorectal Cancer , 2009, CA: a cancer journal for clinicians.

[72]  A. Olshan,et al.  Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. , 2009, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[73]  Paolo Boffetta,et al.  High‐temperature beverages and foods and esophageal cancer risk—A systematic review , 2009, International journal of cancer.

[74]  H. Tsukuma,et al.  Trends in cancer incidence and mortality in Osaka, Japan: Evaluation of cancer control activities , 2009, Cancer science.

[75]  P. van’t Veer,et al.  Green tea drinking, high tea temperature and esophageal cancer in high‐ and low‐risk areas of Jiangsu Province, China: A population‐based case–control study , 2009, International journal of cancer.

[76]  S. Akiba,et al.  Tobacco chewing and female oral cavity cancer risk in Karunagappally cohort, India , 2009, British Journal of Cancer.

[77]  K. Lakshmaiah,et al.  HPV screening for cervical cancer in rural India. , 2009, The New England journal of medicine.

[78]  Prabhat Jha,et al.  Avoidable global cancer deaths and total deaths from smoking , 2009, Nature Reviews Cancer.

[79]  Jacques Ferlay,et al.  Recent patterns in gastric cancer: A global overview , 2009, International journal of cancer.

[80]  F. Chang,et al.  Increasing trend of the incidence of esophageal squamous cell carcinoma, but not adenocarcinoma, in Taiwan , 2010, Cancer Causes & Control.

[81]  R. Malekzadeh,et al.  Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study , 2009, BMJ : British Medical Journal.

[82]  W. Chow,et al.  Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977–2005 , 2009, British Journal of Cancer.

[83]  Helen Farrugia,et al.  Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia , 2009, The Medical journal of Australia.

[84]  A. Weill,et al.  Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006. , 2009, Bulletin du cancer.

[85]  Ahmedin Jemal,et al.  International Trends in Colorectal Cancer Incidence Rates , 2009, Cancer Epidemiology Biomarkers & Prevention.

[86]  S. Altekruse,et al.  Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[87]  Angela Mariotto,et al.  Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. , 2009, Journal of the National Cancer Institute.

[88]  R. Lambert,et al.  Mass screening for colorectal cancer is not justified in most developing countries , 2009, International journal of cancer.

[89]  P. Baade,et al.  International epidemiology of prostate cancer: geographical distribution and secular trends. , 2009, Molecular nutrition & food research.

[90]  C. la Vecchia,et al.  An age-period-cohort analysis of gastric cancer mortality from 1950 to 2007 in Europe. , 2010, Annals of epidemiology.

[91]  A. Jemal,et al.  Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates , 2010, Cancer.

[92]  E. Munck‐Wikland,et al.  The role of human papillomavirus in the increased incidence of base of tongue cancer , 2010, International journal of cancer.

[93]  S. Rosso,et al.  New data tells us more about cancer incidence in North Africa. , 2010, European journal of cancer.

[94]  D. Parkin,et al.  Changing cancer incidence in Kampala, Uganda, 1991–2006 , 2010, International journal of cancer.

[95]  C. Wen,et al.  Cancer risks from betel quid chewing beyond oral cancer: a multiple-site carcinogen when acting with smoking , 2010, Cancer Causes & Control.

[96]  A. Zuckerman,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.

[97]  L. Bruni,et al.  Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. , 2010, The Journal of infectious diseases.

[98]  Hai-rim Shin,et al.  Epidemiology of cholangiocarcinoma: An update focusing on risk factors , 2010, Cancer science.

[99]  F. Bray,et al.  Lung cancer mortality trends in 36 European countries: secular trends and birth cohort patterns by sex and region 1970–2007 , 2010, International journal of cancer.

[100]  A. Jemal,et al.  Global Patterns of Cancer Incidence and Mortality Rates and Trends , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[101]  Ahmedin Jemal,et al.  Breast cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.

[102]  C. Adebamowo,et al.  Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. , 2011, The Lancet. Oncology.

[103]  Ahmedin Jemal,et al.  International Trends in Liver Cancer Incidence Rates , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[104]  Philippe Autier,et al.  Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database , 2011, BMJ : British Medical Journal.

[105]  S. J. Henley,et al.  State-specific trends in lung cancer incidence and smoking--United States, 1999-2008. , 2011, MMWR. Morbidity and mortality weekly report.

[106]  Esther Kim,et al.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[107]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[108]  C. la Vecchia,et al.  Recent trends in colorectal cancer mortality in Europe , 2011, International journal of cancer.

[109]  Alan D. Lopez,et al.  Stages of the cigarette epidemic on entering its second century , 2012, Tobacco Control.

[110]  T. Wright,et al.  Alternative approaches to cervical cancer screening for developing countries. , 2012, Best practice & research. Clinical obstetrics & gynaecology.

[111]  R. Peto,et al.  Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys , 2012, The Lancet.

[112]  C. la Vecchia,et al.  The decline in breast cancer mortality in Europe: an update (to 2009). , 2012, Breast.

[113]  M. Thun,et al.  American Cancer Society guidelines on nutrition and physical activity for cancer prevention , 2002, CA: a cancer journal for clinicians.

[114]  C. la Vecchia,et al.  Lung cancer mortality in European women: trends and predictions. , 2012, Lung cancer.

[115]  H. Weir,et al.  Esophageal cancer in Canada: trends according to morphology and anatomical location. , 2012, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[116]  L. Tanoue,et al.  Reduced lung cancer mortality with low-dose computed tomographic screening , 2011 .

[117]  Susanna M Cramb,et al.  The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. , 2012, Cancer epidemiology.

[118]  M. Plummer,et al.  Global burden of human papillomavirus and related diseases. , 2012, Vaccine.

[119]  Sabha Rasool,et al.  Esophageal Cancer: Associated Factors with Special Reference to the Kashmir Valley , 2012, Tumori.

[120]  K. Li,et al.  Trends in cancer mortality in China: an update. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[121]  A. Jemal,et al.  International variation in prostate cancer incidence and mortality rates. , 2012, European urology.

[122]  M. Plummer,et al.  Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. , 2012, The Lancet. Oncology.

[123]  R. Malekzadeh,et al.  InterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markers. , 2012, Journal of the National Cancer Institute.

[124]  J. Witte,et al.  Global Patterns of Prostate Cancer Incidence, Aggressiveness, and Mortality in Men of African Descent , 2013, Prostate cancer.

[125]  M. Poljak,et al.  Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia. , 2013, Vaccine.

[126]  S. Garland,et al.  The Aetiological Role of Human Papillomavirus in Oesophageal Squamous Cell Carcinoma: A Meta-Analysis , 2013, PloS one.

[127]  D. Saslow,et al.  Cancer screening in the United States, 2013 , 2013, CA: a cancer journal for clinicians.

[128]  D. Parkin,et al.  Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991–2010 , 2013, International journal of cancer.

[129]  M. Lai,et al.  Thirty-year outcomes of the national hepatitis B immunization program in Taiwan. , 2013, JAMA.

[130]  M. Yuen,et al.  Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection. , 2013, World journal of gastroenterology.

[131]  S. Devesa,et al.  Incidence of potentially human papillomavirus–related neoplasms in the United States, 1978 to 2007 , 2013, Cancer.

[132]  C. la Vecchia,et al.  Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[133]  Sahil Mittal,et al.  Epidemiology of hepatocellular carcinoma: consider the population. , 2013, Journal of clinical gastroenterology.

[134]  Wanqing Chen,et al.  Nasopharyngeal carcinoma incidence and mortality in China in 2009 , 2013, Chinese journal of cancer.

[135]  S. Spechler,et al.  Barrett esophagus and risk of esophageal cancer: a clinical review. , 2013, JAMA.

[136]  D. Forman,et al.  Kaposi sarcoma trends in Uganda and Zimbabwe: A sustained decline in incidence? , 2013, International journal of cancer.

[137]  Lihong Qi,et al.  Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study. , 2013, Journal of the National Cancer Institute.

[138]  J. Lagergren,et al.  Recent developments in esophageal adenocarcinoma , 2013, CA: a cancer journal for clinicians.

[139]  M. Plummer,et al.  Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors. , 2013, European journal of cancer.

[140]  H. Jin,et al.  Helicobacter pylori infection and esophageal cancer risk: an updated meta-analysis. , 2013, World journal of gastroenterology.

[141]  Robert N. Anderson,et al.  Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels , 2013, Journal of the National Cancer Institute.

[142]  Fang Yong,et al.  Human papillomavirus types 16 and 18 in esophagus squamous cell carcinoma: a meta-analysis. , 2013, Annals of epidemiology.

[143]  S. Promthet,et al.  Development of a community-based approach to opisthorchiasis control. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[144]  Eva Negri,et al.  Lung cancer mortality in European men: trends and predictions. , 2013, Lung cancer.

[145]  C. Mathers,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .

[146]  E. Negri,et al.  Lung cancer mortality in European men and women : trends and predictions , 2013 .

[147]  J. Luketich,et al.  Oesophageal carcinoma , 2013, The Lancet.

[148]  S. Sangrajrang,et al.  Organised colorectal cancer screening in Lampang Province, Thailand: preliminary results from a pilot implementation programme , 2014, BMJ Open.

[149]  A. Jemal,et al.  Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer , 2014, Cancer.

[150]  C. Pairojkul,et al.  Roles of liver fluke infection as risk factor for cholangiocarcinoma , 2014, Journal of hepato-biliary-pancreatic sciences.

[151]  M. Cooperberg,et al.  Expected population impacts of discontinued prostate‐specific antigen screening , 2014, Cancer.

[152]  A. Olshan,et al.  Prevalence of human papillomavirus among oesophageal squamous cell carcinoma cases: systematic review and meta-analysis , 2014, British Journal of Cancer.

[153]  D. Parkin,et al.  Trends in the incidence of cancer in Kampala, Uganda 1991–2010 , 2014, International journal of cancer.

[154]  A. Jemal,et al.  International trends in head and neck cancer incidence rates: differences by country, sex and anatomic site. , 2014, Oral oncology.

[155]  L. Gravitz Liver cancer , 2014, Nature.

[156]  F. Vleggaar,et al.  Surveillance of Barrett's Esophagus and Mortality from Esophageal Adenocarcinoma: A Population-Based Cohort Study , 2014, The American Journal of Gastroenterology.

[157]  M. Cruz-Correa,et al.  Endoscopic surveillance of gastrointestinal premalignant lesions: current knowledge and future directions , 2014, Current opinion in gastroenterology.

[158]  A. Jemal,et al.  International Variation in Lung Cancer Mortality Rates and Trends among Women , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[159]  J. Lacy,et al.  A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer (Review) , 2014, Oncology letters.

[160]  V. Beral,et al.  Trends in mortality from major cancers in the Americas: 1980-2010. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[161]  A. Cohen,et al.  Outdoor Particulate Matter Exposure and Lung Cancer: A Systematic Review and Meta-Analysis , 2014, Environmental Health Perspectives.

[162]  Wanqing Chen,et al.  Nasopharyngeal carcinoma incidence and mortality in China in 2010 , 2014, Chinese journal of cancer.

[163]  Timothy J Wilt,et al.  Prevention and early detection of prostate cancer. , 2014, The Lancet. Oncology.

[164]  D. Ransohoff,et al.  Multitarget stool DNA testing for colorectal-cancer screening. , 2014, The New England journal of medicine.

[165]  C. la Vecchia,et al.  Patterns and trends in esophageal cancer mortality and incidence in Europe (1980-2011) and predictions to 2015. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[166]  A. Jemal,et al.  International variations in bladder cancer incidence and mortality. , 2014, European urology.

[167]  A. Aplogan,et al.  From the Centers for Disease Control and Prevention , 2015 .

[168]  M. Plummer,et al.  Global burden of gastric cancer attributable to Helicobacter pylori , 2015, International journal of cancer.

[169]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.